Treatment of Chemotherapy-Induced Thrombotic Microangiopathy with Eculizumab in a Patient with Metastatic Breast Cancer

The unexpected occurrence of thrombotic microangiopathy (TMA), characterised by microangiopathic haemolytic anaemia and thrombocytopenia, in a patient with cancer requires urgent diagnosis and appropriate management. TMA in patients with metastatic cancer can be a manifestation of the malignancy its...

Full description

Bibliographic Details

Published in:	Case Reports in Oncology
Main Authors:	Martin Hausberg, Helmut Felten, Stefan Pfeffer
Format:	Article
Language:	English
Published:	Karger Publishers 2019-01-01
Subjects:	aHUS Atypical Haemolytic Syndrome Bevacizumab Breast cancer Complement Eculizumab Metastases Mitomycin Thrombotic microangiopathy
Online Access:	https://www.karger.com/Article/FullText/495031